164 related articles for article (PubMed ID: 20397923)
1. Patient-based strategy for systemic treatment of metastatic renal cell carcinoma.
Kirchner H; Strumberg D; Bahl A; Overkamp F
Expert Rev Anticancer Ther; 2010 Apr; 10(4):585-96. PubMed ID: 20397923
[TBL] [Abstract][Full Text] [Related]
2. Immunochemotherapy-associated protein patterns in tumour tissue and serum of patients with metastatic renal cell carcinoma.
Walter M; Heinze C; Steiner T; Pilchowski R; von Eggeling F; Wunderlich H; Junker K
Arch Physiol Biochem; 2010; 116(4-5):197-207. PubMed ID: 20836751
[TBL] [Abstract][Full Text] [Related]
3. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
Harshman LC; Srinivas S
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.
Gupta K; Miller JD; Li JZ; Russell MW; Charbonneau C
Cancer Treat Rev; 2008 May; 34(3):193-205. PubMed ID: 18313224
[TBL] [Abstract][Full Text] [Related]
5. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
Halbert RJ; Figlin RA; Atkins MB; Bernal M; Hutson TE; Uzzo RG; Bukowski RM; Khan KD; Wood CG; Dubois RW
Cancer; 2006 Nov; 107(10):2375-83. PubMed ID: 17048248
[TBL] [Abstract][Full Text] [Related]
6. Defining an individualized treatment strategy for metastatic renal cancer.
Hu B; Lara PN; Evans CP
Urol Clin North Am; 2012 May; 39(2):233-49, vii. PubMed ID: 22487765
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
Bex A; Gore M; Mulders P; Sternberg CN
BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic renal cell carcinoma.
Reeves DJ; Liu CY
Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
[TBL] [Abstract][Full Text] [Related]
9. Impact of anti-angiogenic treatments on metastatic renal cell carcinoma.
Ainsworth NL; Lee JS; Eisen T
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1793-805. PubMed ID: 19954291
[TBL] [Abstract][Full Text] [Related]
10. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
Wood CG
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
[TBL] [Abstract][Full Text] [Related]
11. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
Pandha H
Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
[No Abstract] [Full Text] [Related]
12. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
[TBL] [Abstract][Full Text] [Related]
15. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
Parton M; Gore M; Eisen T
J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
[TBL] [Abstract][Full Text] [Related]
16. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
Gupta SK; Vogelzang N
Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
[No Abstract] [Full Text] [Related]
17. What is new in kidney cancer?
Kirkali Z
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1753-5. PubMed ID: 19954286
[TBL] [Abstract][Full Text] [Related]
18. Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.
Sfoungaristos S; Giannitsas K; Perimenis P
Expert Opin Pharmacother; 2011 Mar; 12(4):533-47. PubMed ID: 21306289
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
Atzpodien J; Kirchner H; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():38-43. PubMed ID: 8692118
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
